Search research articles
Contact Us
Filters
Showing results (41-50 of 64) with videos related to
Page
of 7
Sort By:
Journal of Immunological Methods
|
April 9, 2001
Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells
A M Asemissen, D Nagorsen, U Keilholz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 20, 2003
Brain metastases following interleukin-2 plus interferon-alpha-2a therapy: a follow-up study in 94 stage IV melanoma patients
A Schmittel, T Proebstle, R Engenhart-Cabillic, et al.
Melanoma Research
|
April 1, 1995
Restriction of T cell receptor V beta repertoire in melanoma metastasis responding to immunotherapy
T Möhler, M Willhauck, C Scheibenbogen, et al.
Cancer Immunology, Immunotherapy : CII
|
February 1, 1994
Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha
R Landmann, U Keilholz, C Scheibenbogen, et al.
Journal of Immunological Methods
|
October 16, 1996
A sensitive proliferation assay to determine the specific T cell response against HLA-A2.1-binding peptides
S Mayer, C Scheibenbogen, K H Lee, et al.
Journal of Leukocyte Biology
|
June 1, 1990
Surface phenotype analysis of human monocyte to macrophage maturation
R Andreesen, W Brugger, C Scheibenbogen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 4, 2000
Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma
C Scheibenbogen, A Schmittel, U Keilholz, et al.
Melanoma Research
|
August 1, 1995
Addition of dacarbazine or cisplatin to interferon-alpha/interleukin-2 in metastatic melanoma: toxicity and immunological effects
U Keilholz, C Scheibenbogen, T Möhler, et al.
Melanoma Research
|
August 1, 1997
UV-induced N-ras mutations are T-cell targets in human melanoma
A van Elsas, C Scheibenbogen, C van der Minne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1997
A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients
C Scheibenbogen, K H Lee, S Mayer, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 64) with videos related to
Sort By:
Page
of 7
Journal of Immunological Methods
|
April 9, 2001
Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells
A M Asemissen, D Nagorsen, U Keilholz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 20, 2003
Brain metastases following interleukin-2 plus interferon-alpha-2a therapy: a follow-up study in 94 stage IV melanoma patients
A Schmittel, T Proebstle, R Engenhart-Cabillic, et al.
Melanoma Research
|
April 1, 1995
Restriction of T cell receptor V beta repertoire in melanoma metastasis responding to immunotherapy
T Möhler, M Willhauck, C Scheibenbogen, et al.
Cancer Immunology, Immunotherapy : CII
|
February 1, 1994
Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha
R Landmann, U Keilholz, C Scheibenbogen, et al.
Journal of Immunological Methods
|
October 16, 1996
A sensitive proliferation assay to determine the specific T cell response against HLA-A2.1-binding peptides
S Mayer, C Scheibenbogen, K H Lee, et al.
Journal of Leukocyte Biology
|
June 1, 1990
Surface phenotype analysis of human monocyte to macrophage maturation
R Andreesen, W Brugger, C Scheibenbogen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 4, 2000
Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma
C Scheibenbogen, A Schmittel, U Keilholz, et al.
Melanoma Research
|
August 1, 1995
Addition of dacarbazine or cisplatin to interferon-alpha/interleukin-2 in metastatic melanoma: toxicity and immunological effects
U Keilholz, C Scheibenbogen, T Möhler, et al.
Melanoma Research
|
August 1, 1997
UV-induced N-ras mutations are T-cell targets in human melanoma
A van Elsas, C Scheibenbogen, C van der Minne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1997
A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients
C Scheibenbogen, K H Lee, S Mayer, et al.
Page
of 7